Working...
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT01132664
Brief Title: Phase 1b/2 Study of BKM120 Plus Trastuzumab in Patients With HER2-positive Breast Cancer

First Submitted : May 7, 2010
First Submitted that Met QC Criteria : May 27, 2010
First Posted : May 28, 2010 (Estimate)

Results First Submitted : August 4, 2015
Results First Submitted that Met QC Criteria : September 29, 2015
Results First Posted : October 30, 2015 (Estimate)

Last Update Submitted that Met QC Criteria : August 9, 2016
Last Update Posted : August 17, 2016 (Estimate)